ALFA Finder
15:20 IST
BSE
Board Meeting Date
Bafna Pharmaceuticals Board Meeting Date
Bafna Pharmaceuticals will consider unaudited standalone quarterly results on 11 November 2026. Trading window stays closed until 13 November 2026.
Bafna Pharmaceuticals Ltd
- Share price
- ₹482.25
- Market cap
- ₹1,141 Cr
- Revenue (annual)
- ₹150.6 Cr
- Net profit (annual)
- ₹11.10 Cr
- P/E (TTM)
- 99.1×Sector 43.8×
- Promoter holding
- 75.00%+0.00% QoQ
- FII holding
- 9.34%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Financial Results 4Board Meeting Date 3Other Announcement 2Annual General Meeting 2Price Movement Clarification 1Annual Report 1
Time
3 announcements with these filters
17:01 IST
BSE
Board Meeting Date
Bafna Pharmaceuticals Board Meeting Date
Bafna Pharmaceuticals has scheduled a board meeting for August 11, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.
17:58 IST
BSE
Board Meeting Date
Bafna Pharmaceuticals Board Meeting Date
Bafna Pharmaceuticals scheduled a board meeting for May 29, 2026, to approve audited financial results. The trading window remains closed until May 31, 2026.